Jena Acquisition Corporation II (JENA) 股票分析
金融服务Jena Acquisition Corporation II
$10.29
+$0.00 (+0.00%)
最后更新: 2026年5月26日
价格走势
暂无价格数据
分析
公司概述
Jena Acquisition Corporation II is a special purpose acquisition company structured to execute a business combination through mergers, amalgamations, share exchanges, asset acquisitions, or similar transactions with one or more target businesses. The entity operates within the Financial Services sector, specifically classified under the industry of Shell Companies, which typically indicates a temporary corporate structure awaiting a definitive merger or acquisition rather than a traditional operating business. As of the latest available data, the company holds a market capitalization of $296.12 million, while its annual revenue and total employee count are not publicly disclosed in the provided financial records. This market cap figure suggests that the company possesses a significant but non-trivial valuation relative to many emerging SPACs, reflecting the capital raised to facilitate its upcoming business combination, whereas the lack of disclosed revenue highlights that the company has not yet generated operating income from a commercial business, a standard characteristic for shell companies prior to their merger completion.
财务健康
The company reported a net income of $-1,836,775 for the trailing twelve-month period, with revenue and EBITDA figures listed as not available, a situation typical for SPACs that have not yet consummated a merger. The substantial gap between the reported revenue (which is effectively zero or unreported) and the negative net income reveals a cost structure dominated by organizational and administrative expenses rather than cost of goods sold or operating costs. Free cash flow is not available, indicating that the company's liquidity is currently derived primarily from its cash reserves rather than operational cash generation. The company maintains a cash balance of $913,121, while its total debt stands at $0, resulting in a debt-to-equity ratio that is not applicable due to the absence of equity or debt figures in the standard reporting format. This financial position, characterized by zero debt, suggests a highly conservative balance sheet designed to preserve capital for the upcoming business combination. All three margins—gross margin, operating margin, and profit margin—are recorded at 0.0%, which indicates that the company has not yet established a profitable revenue stream or operational infrastructure prior to its merger. The current ratio is reported at 42.56, a figure that signifies an exceptionally strong short-term liquidity position relative to its current liabilities, providing ample buffer for operational needs. Return on equity and return on assets are both not available, reflecting that management effectiveness cannot yet be measured in terms of traditional profitability metrics since the company has not yet generated positive earnings or substantial asset turnover.
估值评估
The trailing P/E ratio and forward P/E ratio are both not available, as the company is currently unprofitable and lacks the earnings necessary to calculate these traditional valuation metrics, which implies that the market is not pricing in current earnings growth but rather future merger prospects. The price-to-book ratio is reported at -23.33, a negative figure that indicates the market capitalization is priced significantly below the book value of equity, a common phenomenon for SPACs with substantial cash on hand where the asset base is inflated by undistributed proceeds. Price-to-sales ratio and EV/EBITDA are also not available, suggesting that alternative valuation methods relying on revenue multiples or enterprise value are not applicable until the company generates sales or achieves profitability post-merger. Over the past year, the stock has traded between a 52-week low of $10.06 and a 52-week high of $10.50, placing the current trading price in close proximity to the upper end of this narrow range. The beta value is not available, meaning that the stock's volatility relative to the broader market cannot be quantified using historical correlation data. These valuation characteristics underscore the speculative nature of the investment, where value is derived from the potential of the underlying business combination rather than existing financial fundamentals or historical price volatility metrics.
Growth & Income
Revenue growth and earnings growth year-over-year are both not available, as the company has not yet entered its commercial operating phase to generate comparable financial data for growth analysis. Consequently, the company does not pay dividends, as indicated by a dividend yield that is not available and a payout ratio of 0.0%, reflecting the standard practice for SPACs to retain all earnings for the business combination rather than distributing them to shareholders. This reinvestment strategy is consistent with the lifecycle of a shell company, where capital is reserved exclusively for transaction costs and the integration of the target business rather than shareholder distributions. The overall growth and income profile is defined by the absence of current operational metrics, with the primary value driver being the successful execution of the planned merger rather than organic revenue expansion or dividend income generation.
同行比较
Jena Acquisition Corporation II (JENA) 在壳公司行业运营。以下是其与市值最接近的同行的比较:
| 公司 | 代码 | 市值 | 市盈率 |
|---|---|---|---|
| Jena Acquisition Corporation II | JENA | $298.15M | N/A |
| Twenty One Capital, Inc. | XXI | $2.49B | N/A |
| Churchill Capital Corp X | CCCX | $711.00M | N/A |
| Drugs Made In America Acquisition II Corp. | DMII | $641.46M | 77.5 |
壳公司行业平均市盈率为82.8倍。Jena Acquisition Corporation II的市盈率为N/A。
本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。
相关壳公司股票
Twenty One Capital, Inc.
$2.49B
CCCXChurchill Capital Corp X
$711.00M
DMIIDrugs Made In America Acquisition II Corp.
$641.46M
BCSSBain Capital GSS Investment Corp.
$595.68M
EVACEQV Ventures Acquisition Corp. II
$594.41M
CEPFCantor Equity Partners IV, Inc.
$591.50M
金融服务热门股票
Berkshire Hathaway Inc.
$1.38T
BRK-BBerkshire Hathaway Inc.
$1.04T
BRK-ABerkshire Hathaway Inc.
$1.04T
JPMJPMorgan Chase & Co.
$821.91B
VVisa Inc.
$620.88B
关于Jena Acquisition Corporation II
Jena Acquisition Corporation II focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Jena Acquisition Corporation II was incorporated in 2025 and is based in Las Vegas, Nevada.
公司简介以英文显示。